Investigation of the interaction between the MIR-503 and CD40 genes in irradiated U937 cells

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Cheng, Guanghui ^a   Sun, Shilong ^b   Wang, Zhanfeng ^a,c   Jin, Shunzi ^b  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

^c BEIHUA UNIVERSITY   (China)

Author keywords

CD40; miR 503; Radiation

Indexed keywords

CD40 ANTIGEN; LUCIFERASE; MICRORNA; MICRORNA 503; UNCLASSIFIED DRUG; MIRN503 MICRORNA, HUMAN;

ARTICLE; BIOINFORMATICS; DOWN REGULATION; ENZYME ASSAY; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IONIZING RADIATION; RADIATION DOSE; UPREGULATION; CELL STRAIN U937; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; RADIATION EXPOSURE;

ANTIGENS, CD40; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; RADIATION, IONIZING; U937 CELLS;

EID: 84862792307     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-38     Document Type: Article

References (24)

1. Amundson SA. Functional genomics in radiation biology: a gateway to cellular systems-level studies. Radiat Environ Biophys 2008, 47(1):25-31. 10.1007/s00411-007-0140-1, 17973116.
2. Preston RJ. Radiation biology: concepts for radiation protection. Health Phys 2005, 88(6):545-556. 10.1097/00004032-200506000-00003, 15891452.
3. Amundson SA, Bittner M, Fornace AJ. Functional genomics as a window on radiation stress signaling. Oncogene 2003, 22(37):5828-5833. 10.1038/sj.onc.1206681, 12947389.
4. Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40/CD154 engagement in the immune system. Immunol Rev 2009, 229(1):152-172. 10.1111/j.1600-065X.2009.00782.x, 19426221.
5. Callard RE, Armitage RJ, Fanslow WC, Spriggs MK. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today 1993, 14(11):559-564. 10.1016/0167-5699(93)90188-Q, 7506037.
6. Zhang Y, Cao HJ, Graf B, Meekins H, Smith TJ, Phipps RP. CD40 engagement up-regulates cyclooxygenase-2 expression and prostaglandin E2 productionin human lung fibroblasts. J Immunol 1998, 160(3):1053-1057.
7. Tan J, Town T, Mori T, Obregon D, Wu Y, DelleDonne A, Rojiani A, Crawford F, Flavell RA, Mullan M. CD40 is expressed and functional on neuronal cells. EMBO J 2002, 21(4):643-652. 10.1093/emboj/21.4.643, 125862, 11847112.
8. Young LS, Eliopoulos AG, Gallagher NJ, Dawson CW. CD40 and epithelial cells: across the great divide. Immunol Today 1998, 19(11):502-505. 10.1016/S0167-5699(98)01340-1, 9818543.
9. Liu J. Control of protein synthesis and mRNA degradation by microRNAs. Curr Opin Cell Biol 2008, 20(2):214-221. 10.1016/j.ceb.2008.01.006, 18329869.
10. Wagner-Ecker M, Schwager C, Wirkner U, Abdollahi A, Huber PE. MicroRNA expression after ionizing radiation in human endothelial cells. Radiat Oncol 2010, 5:25. 10.1186/1748-717X-5-25, 2859352, 20346162.
11. Zhou J, Wang W. Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell. J Surg Oncol 2011, 104(3):278-283. 10.1002/jso.21941, 21495032.
12. Boominathan L. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS One 2010, 5(5):e10615. 10.1371/journal.pone.0010615, 2868896, 20485546.
13. Weidhaas JB, Babar I, Nallur SM, Trang P, Roush S, Boehm M, Gillespie E, Slack FJ. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 2007, 67(23):11111-11116. 10.1158/0008-5472.CAN-07-2858, 18056433.
14. Jeong SH, Wu HG, Park WY. LIN28B confers radio-resistance through the posttranscriptional control of KRAS. Exp Mol Med 2009, 41(12):912-918. 10.3858/emm.2009.41.12.097, 2802686, 19745602.
15. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, (34 Database):D140-D144.
16. Nam S, Li M, Choi K, Balch C, Kim S, Nephew KP. MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression. Nucleic Acids Res 2009, (37 Web Server):W356-W362.
17. Akao Y, Nakagawa Y, Naoe T. MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep 2006, 16(4):845-850.
18. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. A microRNA expression signatureof human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103(7):2257-2261. 10.1073/pnas.0510565103, 1413718, 16461460.
19. Welch C, Chen Y, Stallings RL. MicroRNA-34a functions asa potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007, 26(34):5017-5022. 10.1038/sj.onc.1210293, 17297439.
20. Chen Y, Stallings RL. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res 2007, 67(3):976-983. 10.1158/0008-5472.CAN-06-3667, 17283129.
21. Lindsay MA. microRNAs and the immune response. Trends Immunol 2008, 29(7):343-351. 10.1016/j.it.2008.04.004, 18515182.
22. Lodish HF, Zhou B, Liu G, Chen CZ. Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008, 8(2):120-130. 10.1038/nri2252, 18204468.
23. Sonkoly E, Ståhle M, Pivarcsi A. MicroRNAs and immunity: novelplayers in the regulation of normal immune function and inflammation. Semin Cancer Biol 2008, 18(2):131-140. 10.1016/j.semcancer.2008.01.005, 18291670.
24. Kwak H, Jeong KC, Chae MJ, Kim SY, Park WY. Flavonoids inhibit the AU-rich element binding of HuC. BMB Rep 2009, 42(1):41-46. 10.5483/BMBRep.2009.42.1.041, 19192392.